Impact Asset Management Gmbh / REGN
Impact Asset Management Gmbh’s Regeneron Pharmaceuticals Position
Does Impact Asset Management Gmbh own Regeneron Pharmaceuticals (REGN)? Yes — 6.8K shares worth $4M (+1.68% of its 13F portfolio) as of Q2 2025, up from 6.5K shares the prior filed quarter.
Position Value
$4M
Q2 2025
Shares
6.8K
% of Portfolio
+1.68%
Quarters Held
2
currently held
Position History REGN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Impact Asset Management Gmbh’s full portfolio or all institutional holders of REGN.